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Although colonic carcinoma is the major longterm complication of ulcerative colitis, primary colonic lymphoma has also been shown to be associated with ulcerative colitis. As the clinical symptoms of chronic inflammatory bowel disease and malignant lymphoma of the large bowel can be very similar, diagnosis of lymphoma can be masked and correct treatment may be delayed. We report a case of a patient suffering from ulcerative colitis for more than two years when malignant lymphoma of the colon developed. The diagnosis was made after treatment failure of the colitis with corticosteroids, azathioprine, and sulphasalazine.
Case report A 51 year old woman suffering from ulcerative colitis since 1989 was transferred to our hospital in 1991 because of ineffective longterm treatment with corticosteroids, azathioprine, and sulphasalazine. First endoscopy of the colon and histological examination in 1989 showed chronic inflammatory bowel disease with typical signs of ulcerative colitis (Figs 1 and 2) involving the entire colon and the terminal ileum. Different therapeutic strategies including total parenteral or enteral nutrition had not improved the symptoms, which were dominated by 10-15 bloody stools a day.
When we saw the patient in 199 1, she presented with a slightly painful abdomen with normal peristalsis, no superficial lymphadenopathy, no hepatosplenomegaly. Laboratory examinations showed mild inflammatory Colonoscopy showed a mild form of acute ulcerative colitis. Histological examination of the stomach and duodenal biopsy specimens showed not only typical polymorphonuclear inflammatory infiltration, but also distinct lymphocytic infiltration (Figs 3 and 4), which was even more evident in the colonic biopsy specimens (Fig 5A) . In all sections the lymphocytic infiltration invaded the mucosa forming lymphoepithelial lesions and destroying the mucosal glands, typical evidence for the presence of primary gastrointestinal malignant lymphoma of MALT type (Fig 5B) . Cells showed typical cleaved nuclei reminiscent of centrocytic cells (Fig 5C) . Characteristic signs for acute ulcerative colitis were no longer detectable. Further immunocytochemistry confirmed this to be a B cell lymphoma (Fig 6) . Histological examination of the bone marrow showed invasion of the malignant lymphoma, which had already led to a 40% suppression of bone marrow cells (Fig 7) .
Summarising the results, our patient had developed a low grade B cell non-Hodgkin's lymphoma involving the upper and lower gastrointestinal tract and the bone marrowthat is, stage IV. The enlargement of abdominal lymph nodes and spleen was probably also caused by distant lymphoma spread.
TREATMENT
The patient received chemotherapy according to the CVP protocol: cyclophosphamide 400 mg/m2, vincristine 1.4 mg/m2, prednisone 60 mg/m2. After three courses, there was a decrease in diarrhoea from 10 to 5 stools daily with no blood contamination. Continuation of the chemotherapy for another three courses did not result in any further decrease in stool frequency. Repeated colonoscopy and bone marrow investigation, however, showed a progressive reduction of the lymphocytic infiltration. After chemotherapy had ended, the colon endoscopically showed typical changes as seen after long standing chronic inflammation of the colon with reduced haustration, but no evidence for acute disorder. Histologically, the malignant lymphoma was no longer present. Bone marrow was also free of lymphocytic infiltration. Abdominal computed tomography showed normal size of spleen and normal lymph nodes.
Discussion
Primary gastrointestinal lymphomas occur between 1 and 4% of all gastrointestinal malignancies. 1 The gastrointestinal tract is the commonest site of extranodal lymphomas.2 In western populations, the stomach is most commonly involved, while colorectal lymphoma comprises between 10 In conclusion, malignant lymphoma of the bowel is a rare but significant complication of inflammatory bowel disease, apparently being more common in chronic ulcerative colitis than in Crohn's disease. It is quite conceivable that the changed lymphoid populations in inflammatory bowel disease represents the clones in which lymphoma arises. Therefore, it is important to evaluate any lymphocytic infiltrate seen in a biopsy specimen, especially when anti-inflammatory treatment seems to be ineffective. 
